Vardenafil proven to be safe in male patients with coronary artery disease

Published: 2002-03-26 06:58:00

Updated: 2002-03-26 06:58:00

The recent studies have demonstrated that Vardenafil, which was developed by Bayer as anti-impotence drug, has a safety profile in male patient with coronary artery disease, since it do not cause any ischemic symptom.

According to the reports released by the National Heart Assocation' in its 5...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK